Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DHR - DANAHER CORP /DE/


204.09
-0.870   -0.426%

Share volume: 2,455,981
Last Updated: 03-13-2025
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$204.96
-0.87
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
60%
Profitability 54%
Dept financing 39%
Liquidity 48%
Performance 75%
Company vs Stock growth
vs
Performance
5 Days
-0.56%
1 Month
-1.07%
3 Months
-12.85%
6 Months
-26.06%
1 Year
-19.40%
2 Year
-16.65%
Key data
Stock price
$204.09
P/E Ratio 
42.52
DAY RANGE
$203.22 - $206.82
EPS 
$5.32
52 WEEK RANGE
$196.80 - $281.70
52 WEEK CHANGE
-$18.17
MARKET CAP 
165.798 B
YIELD 
0.47%
SHARES OUTSTANDING 
722.213 M
DIVIDEND
$0.27
EX-DIVIDEND DATE
06-28-2024
NEXT EARNINGS DATE
N/A
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,804,993
AVERAGE 30 VOLUME 
$5,005,078
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 2006
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news